ALN-PCSsc: Updated Phase I data

The partners reported updated data from a single-blind, placebo-controlled, U.K. Phase I trial in 69 healthy subjects on or off statins with elevated baseline LDL-C levels of >100 mg/dL evaluating single and multiple doses

Read the full 344 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE